Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma
Authors
Keywords
-
Journal
ALLERGY
Volume 71, Issue 10, Pages 1472-1479
Publisher
Wiley
Online
2016-04-27
DOI
10.1111/all.12922
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using Exhaled Nitric Oxide and Serum Periostin as a Composite Marker to Identify Severe/Steroid-Insensitive Asthma
- (2014) Tadao Nagasaki et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Comprehensive efficacy of omalizumab for severe refractory asthma: a time-series observational study
- (2014) Tomoko Tajiri et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- “Auto-anti-IgE”: Naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation
- (2014) Yih-Chih Chan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Integrating longitudinal information on pulmonary function and inflammation using asthma phenotypes
- (2014) Tadao Nagasaki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Development of Assay for Determining Free IgE Levels in Serum from Patients Treated with Omalizumab
- (2014) Reiko Ito et al. ALLERGOLOGY INTERNATIONAL
- Serum Periostin: A Novel Biomarker for Asthma Management
- (2014) Hisako Matsumoto ALLERGOLOGY INTERNATIONAL
- Omalizumab in Asthma: An Update on Recent Developments
- (2014) Marc Humbert et al. Journal of Allergy and Clinical Immunology-In Practice
- Exploring the Effects of Omalizumab in Allergic Asthma
- (2013) Nicola A. Hanania et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
- (2013) Nicola A. Hanania et al. ANNALS OF INTERNAL MEDICINE
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effects
- (2013) William Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids
- (2013) Yoshihiro Kanemitsu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Assessment of Long-term Omalizumab Treatment in Patients with Severe Allergic Asthma Long-term Omalizumab Treatment in Severe Asthma
- (2013) Eylem Sercan Özgür et al. JOURNAL OF ASTHMA
- Prevalence and Clinical Relevance of Allergic Rhinitis in Patients with Classic Asthma and Cough Variant Asthma
- (2013) Tomoko Tajiri et al. RESPIRATION
- The eXpeRience registry: The ‘real-world’ effectiveness of omalizumab in allergic asthma
- (2013) G.-J. Braunstahl et al. RESPIRATORY MEDICINE
- Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
- (2012) Guiquan Jia et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Monitoring free serum IgE in severe asthma patients treated with omalizumab
- (2012) Stephanie Korn et al. RESPIRATORY MEDICINE
- Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE
- (2011) Philip J. Lowe et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Long-term omalizumab treatment in severe allergic asthma: The South-Eastern Mediterranean “real-life” experience
- (2011) Eleni G. Tzortzaki et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Anti-inflammatory effects of seven years treatment with Omalizumab in severe uncontrolled asthmatics
- (2010) E. Pace et al. ALLERGY
- Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
- (2010) M. Okamoto et al. EUROPEAN RESPIRATORY JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now